Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cancers|September 13, 2025
HER2 Interactome Profiling Reveals MARCKS as a Candidate Marker Associated with Aggressive Breast CancerAtsushi Yokoyama, Shun Sawatsubashi, Akiko Ebata, et al.
Hormones & Cancer|January 5, 2013
BUB1 immunolocalization in breast carcinoma: its nuclear localization as a potent prognostic factor of the patientsKiyoshi Takagi, Yasuhiro Miki, Yukiko Shibahara, et al.
International Journal of Molecular Sciences|May 13, 2023
Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic MarkerAi Sato, Kiyoshi Takagi, Ayano Yoshimura, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 20, 2025
5α-reductase type 3 is a predictive marker for chemotherapy efficacy in breast cancer in an androgen-independent mannerKanoko Nakamura, Kiyoshi Takagi, Mio Yamaguchi-Tanaka, et al.
Cancer Science|September 3, 2015
Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factorHiroyuki Minemura, Kiyoshi Takagi, Yasuhiro Miki, et al.
Acta Histochemica Et Cytochemica|September 13, 2021
Forkhead Box I1 in Breast Carcinoma as a Potent Prognostic FactorYoshiaki Onodera, Kiyoshi Takagi, Yoshimi Neoi, et al.
IJU Case Reports|November 5, 2024
Distant recurrence of non-muscle invasive bladder cancer 8 years after initial treatmentMahoro Watanabe, Naoki Kawamorita, Tetsuro Shiraiwa, et al.
Cancer Science|October 13, 2011
Nucleobindin 2 in human breast carcinoma as a potent prognostic factorShiho Suzuki, Kiyoshi Takagi, Yasuhiro Miki, et al.
Breast Cancer (Tokyo, Japan)|October 28, 2024
Clinicopathogenomic analysis of PI3K/AKT/PTEN-altered luminal metastatic breast cancer in JapanHiroshi Tada, Minoru Miyashita, Narumi Harada-Shoji, et al.
Acta Histochemica Et Cytochemica|September 8, 2023
Immunolocalization of Cytoplasmic ER in ER-negative Breast Carcinoma as a Potent Favorable Prognostic PredictorAkiko Ebata, Takashi Suzuki, Narumi Shoji-Harada, et al.
Pageof 3